Connection lost
Server error
Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc. Case Brief
Why Top Law Students (And Those Aspiring to Be) Use LSD+ Briefs
Let's be real, law school is a marathon. Our exclusive Flash-to-Full case system is designed by Harvard Law School and MIT grads to match your pace: Quick summaries when you're slammed, detailed analysis when you need to go deep. Only LSD+ offers this kind of flexibility to genuinely fit your study flow.
Adaptive Case Views
Toggle between Flash, Standard, and Expanded. Get what you need, when you need it.
Exam-Ready IRAC Format
We deliver the precise structure professors look for in exam answers.
Complex Cases, Clarified
We break down dense legal reasoning into something digestible, helping you grasp core concepts.
Case Brief Summary & Legal Analysis
tl;dr: A pharmaceutical company’s confidential sale of its invention to a partner triggered the “on sale” bar under the America Invents Act, invalidating its later-issued patent. The Court held that a commercial sale need not make the invention’s details public to bar patentability.
Legal Significance: The case confirms that the America Invents Act did not narrow the “on sale” bar. A commercial sale, even if confidential, can qualify as prior art under 35 U.S.C. § 102(a), preserving the long-standing rule from pre-AIA precedent like Pfaff.
Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc. Law School Study Guide
Use this case brief structure for your own legal analysis. Focus on the IRAC methodology to excel in law school exams and cold calls.
Case Facts & Court Holding
Key Facts & Case Background
Petitioner Helsinn Healthcare S.A. developed a new fixed-dose formulation of palonosetron to treat chemotherapy-induced nausea. In 2001, nearly two years before filing a provisional patent application, Helsinn entered into licensing and supply agreements with MGI Pharma, Inc. These agreements authorized MGI to distribute and sell the specific drug formulation in the United States. The agreements constituted a commercial sale of the yet-to-be-patented invention. While the existence of the agreements was publicly disclosed in press releases and SEC filings, the specific dosage formulation—the core of the invention—was kept confidential under the terms of the contracts. In 2013, Helsinn obtained a patent for the formulation, which was governed by the Leahy-Smith America Invents Act (AIA). When Helsinn sued Teva Pharmaceuticals for infringement, Teva defended by arguing the patent was invalid under the AIA’s “on sale” bar. Teva asserted that the 2001 agreements with MGI placed the invention “on sale” more than one year before Helsinn’s effective patent filing date of January 30, 2003, thus rendering the invention unpatentable prior art.
Court Holding & Legal Precedent
Issue: Does a commercial sale of an invention to a third party, who is contractually obligated to keep the invention confidential, place the invention “on sale” under the Leahy-Smith America Invents Act, thereby qualifying it as prior art that can bar patentability?
Yes. The Court held that a commercial sale to a third party Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
IRAC Legal Analysis
Complete IRAC Analysis for Higher Grades
IRAC (Issue, Rule, Analysis, Conclusion) is the exact format professors want to see in your exam answers. Our exclusive Flash-to-Full briefs combine holding, analysis, and rule statements formatted to match what A+ students produce in exams. These structured briefs help reinforce the essential legal reasoning patterns expected in law school.
Legal Issue
Does a commercial sale of an invention to a third party, who is contractually obligated to keep the invention confidential, place the invention “on sale” under the Leahy-Smith America Invents Act, thereby qualifying it as prior art that can bar patentability?
Conclusion
This decision confirms that the America Invents Act did not substantively change Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
Legal Rule
Under the Leahy-Smith America Invents Act, an invention is "on sale" for Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
Legal Analysis
Writing for a unanimous Court, Justice Thomas centered the analysis on the Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariat
Flash-to-Full Case Opinions
Flash Summary
- A commercial sale of an invention triggers the AIA’s on-sale bar,